Income Taxes - Schedule of significant components of the Company's net deferred tax asset (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Income Tax Disclosure [Abstract]
Net operating loss carryforward	$ 9,776	$ 6,953
Capitalization of research and development expense	2,543	1,841
Credit carryforwards	1,019	799
Stock compensation	1,081	1,043
Lease liability	581	733
Other temporary differences	22	0
Total deferred tax assets	15,022	11,369
Valuation allowance	(14,542)	(10,739)
Net deferred tax assets	480	630
Depreciation	(62)	(94)
Right-of-use asset	(418)	(536)
Net deferred taxes	$ 0	$ 0